Naohiko Ikegaki

2PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.

Florette K Hazard, Angus M S Toland, Serena Y Tan

|May 07, 2022
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma.

Xao X Tang, Hiroyuki Shimada, Naohiko Ikegaki

Pageof 1